UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice

Proceedings of the National Academy of Sciences - PNAS, 2014-06, Vol.111 (22), p.8191-8196

2014

Volltextzugriff (PDF)

Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice

Hypertension (Dallas, Tex. 1979), 2018-12, Vol.72 (6), p.1355-1364

2018

Volltextzugriff (PDF)

Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery Disease

BioMed research international, 2013-01, Vol.2013, p.186215-8

2013

Volltextzugriff (PDF)

Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress

Stroke (1970), 2017-05, Vol.48 (5), p.1362-1368

2017

Volltextzugriff (PDF)

Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes

The FASEB journal, 2017-09, Vol.31 (9), p.4053-4063

2017

Volltextzugriff (PDF)

A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke

Scientific reports, 2016-11, Vol.6 (1), p.38062-38062, Article 38062

2016

Volltextzugriff (PDF)

A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction

Scientific reports, 2017-03, Vol.7 (1), p.43920-43920, Article 43920

2017

Volltextzugriff (PDF)

Long-Term Reduction of High Blood Pressure by Angiotensin II DNA Vaccine in Spontaneously Hypertensive Rats

Hypertension (Dallas, Tex. 1979), 2015-07, Vol.66 (1), p.167-174

2015

Volltextzugriff (PDF)

The dipeptidyl peptidase-4 inhibitor teneligliptin improved endothelial dysfunction and insulin resistance in the SHR/NDmcr-cp rat model of metabolic syndrome

Hypertension research, 2014-03, Vol.37 (7), p.629-635

2014

Volltextzugriff (PDF)

Therapeutic vaccine against DPP4 improves glucose metabolism in mice

Proceedings of the National Academy of Sciences - PNAS, 2014-04, Vol.111 (13), p.E1256-E1263

2014

Volltextzugriff (PDF)

Evaluating the potential of the GFAP‐KLH immune‐tolerizing vaccine for type 1 diabetes in mice

FEBS letters, 2017-01, Vol.591 (1), p.129-136

2017

Volltextzugriff (PDF)

Decrease in blood pressure and regression of cardiovascular complications by angiotensin II vaccine in mice

PloS one, 2013-03, Vol.8 (3), p.e60493

2013

Volltextzugriff (PDF)

Therapeutic Vaccines for Hypertension and Dyslipidemia

International Heart Journal, 2014, Vol.55(2), pp.96-100

2014

Volltextzugriff (PDF)

Long-term expression of periostin during the chronic stage of ischemic stroke in mice

Hypertension research, 2014-06, Vol.37 (6), p.494-499

2014

Volltextzugriff (PDF)

Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice

Vaccines (Basel), 2020-02, Vol.8 (1), p.83

2020

Volltextzugriff (PDF)

Impact of surface coated magnetite used in magnetic drug delivery system on immune response

Journal of applied physics, 2015-05, Vol.117 (17)

2015

Volltextzugriff (PDF)

Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel

Hypertension research, 2012-01, Vol.35 (1), p.77-81

2012

Volltextzugriff (PDF)

Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis

Molecular biology of the cell, 2009-07, Vol.20 (13), p.3115-3124

2009

Volltextzugriff (PDF)

Development of novel DNA vaccine for VEGF in murine cancer model

Scientific reports, 2013-11, Vol.3 (1), p.3380-3380, Article 3380

2013

Volltextzugriff (PDF)

AJP001, a novel helper T‐cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine

FASEB bioAdvances, 2019-12, Vol.1 (12), p.760-772

2019

Volltextzugriff (PDF)

Variation in OSBPL10 is associated with dyslipidemia

Hypertension research, 2010-05, Vol.33 (5), p.511-514

2010

Volltextzugriff (PDF)

Inhibition of neointima formation through DNA vaccination for apolipoprotein(a): a new therapeutic strategy for lipoprotein(a)

Scientific reports, 2013-04, Vol.3 (1), p.1600-1600, Article 1600

2013

Volltextzugriff (PDF)

Unique Remodeling Processes after Vascular Injury in Intracranial Arteries: Analysis Using a Novel Mouse Model

Journal of cerebral blood flow and metabolism, 2013-08, Vol.33 (8), p.1153-1159

2013

Volltextzugriff (PDF)

Peptide Vaccines for Hypertension and Diabetes Mellitus

Vaccines (Basel), 2014-11, Vol.2 (4), p.832-840

2014

Volltextzugriff (PDF)

Identification of Evidence Suggestive of an Association with Peripheral Arterial Disease at the OSBPL10 Locus by Genome-Wide Investigation in the Japanese Population

Journal of Atherosclerosis and Thrombosis, 2010, Vol.17(10), pp.1054-1062

2010

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(113)
Japanisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice

Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice

Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery Disease

Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress

Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes

A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke

A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction

Long-Term Reduction of High Blood Pressure by Angiotensin II DNA Vaccine in Spontaneously Hypertensive Rats

The dipeptidyl peptidase-4 inhibitor teneligliptin improved endothelial dysfunction and insulin resistance in the SHR/NDmcr-cp rat model of metabolic syndrome

Therapeutic vaccine against DPP4 improves glucose metabolism in mice

Evaluating the potential of the GFAP‐KLH immune‐tolerizing vaccine for type 1 diabetes in mice

Decrease in blood pressure and regression of cardiovascular complications by angiotensin II vaccine in mice

Therapeutic Vaccines for Hypertension and Dyslipidemia

Long-term expression of periostin during the chronic stage of ischemic stroke in mice

Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice

Impact of surface coated magnetite used in magnetic drug delivery system on immune response

Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel

Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis

Development of novel DNA vaccine for VEGF in murine cancer model

AJP001, a novel helper T‐cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine

Variation in OSBPL10 is associated with dyslipidemia

Inhibition of neointima formation through DNA vaccination for apolipoprotein(a): a new therapeutic strategy for lipoprotein(a)

Unique Remodeling Processes after Vascular Injury in Intracranial Arteries: Analysis Using a Novel Mouse Model

Peptide Vaccines for Hypertension and Diabetes Mellitus

Identification of Evidence Suggestive of an Association with Peripheral Arterial Disease at the OSBPL10 Locus by Genome-Wide Investigation in the Japanese Population

Suchergebnisse filtern